These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 16556795

  • 1. Use of beta2 agonists in sport: are the present criteria right?
    Naranjo Orellana J, Centeno Prada RA, Carranza Márquez MD.
    Br J Sports Med; 2006 Apr; 40(4):363-6; discussion 366. PubMed ID: 16556795
    [Abstract] [Full Text] [Related]

  • 2. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    Pulmonary Function and Clinical Respiratory Physiology Committee of Chinese Association of Chest Physicians, Chinese Thoracic Society, Pulmonary Function Group of Respiratory Branch of Chinese Geriatric Society.
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb 12; 47(2):101-119. PubMed ID: 38309959
    [Abstract] [Full Text] [Related]

  • 3. β-2 agonists in sport: are the anti-doping rules meeting the needs of asthmatic athletes?
    Orellana JN, Márquez MD.
    Br J Sports Med; 2011 Aug 12; 45(10):809-12. PubMed ID: 19955160
    [Abstract] [Full Text] [Related]

  • 4. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ, Winter TH, Aalbers R.
    Thorax; 2001 Jul 12; 56(7):529-35. PubMed ID: 11413351
    [Abstract] [Full Text] [Related]

  • 5. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B, Wuestenfeld JC, Kindermann W.
    Endocrinol Metab Clin North Am; 2010 Mar 12; 39(1):75-87, ix. PubMed ID: 20122451
    [Abstract] [Full Text] [Related]

  • 6. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH, Hem E, Stensrud T, Held T, Herland K, Mowinckel P.
    Respir Med; 2001 Jul 12; 95(7):571-6. PubMed ID: 11453313
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.
    N Engl J Med; 1992 Oct 22; 327(17):1198-203. PubMed ID: 1357550
    [Abstract] [Full Text] [Related]

  • 8. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S, Swystun VA, Bhagat R, Cockcroft DW.
    Chest; 1996 Apr 22; 109(4):953-6. PubMed ID: 8635376
    [Abstract] [Full Text] [Related]

  • 9. Tolerance to beta-agonists during acute bronchoconstriction.
    Hancox RJ, Aldridge RE, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Town GI, Taylor DR.
    Eur Respir J; 1999 Aug 22; 14(2):283-7. PubMed ID: 10515402
    [Abstract] [Full Text] [Related]

  • 10. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
    Richter K, Janicki S, Jörres RA, Magnussen H.
    Eur Respir J; 2002 May 22; 19(5):865-71. PubMed ID: 12030726
    [Abstract] [Full Text] [Related]

  • 11. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
    Wong AG, O'Byrne PM, Lindbladh C, Inman MD, Stâhl E, Hargreave FE.
    Can Respir J; 1998 May 22; 5(2):119-23. PubMed ID: 9707454
    [Abstract] [Full Text] [Related]

  • 12. Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction.
    van der Woude HJ, Postma DS, Politiek MJ, Winter TH, Aalbers R.
    Respir Med; 2004 Sep 22; 98(9):816-20. PubMed ID: 15338791
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW, van der Mark TW, Koëter GH, Postma DS.
    Am J Respir Crit Care Med; 1996 Jan 22; 153(1):70-5. PubMed ID: 8542165
    [Abstract] [Full Text] [Related]

  • 15. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM, Chapman KR, Della Cioppa G, Stubbing D, Fairbarn MS, Till MD, Brambilla R.
    J Allergy Clin Immunol; 1999 Mar 22; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
    Simons FE, Soni NR, Watson WT, Becker AB.
    J Allergy Clin Immunol; 1992 Nov 22; 90(5):840-6. PubMed ID: 1358932
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.